Green Alpha Advisors’s AbCellera Biologics ABCL Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$80.1K	Sell	22,944 -4,648	-17%	-$16.7K	0.08%	104
2025 Q4	$94.4K	Buy	27,592 +4,817	+21%	+$21.5K	0.09%	112
2025 Q3	$115K	Sell	22,775 -6,328	-22%	-$27.9K	0.11%	96
2025 Q2	$99.8K	Sell	29,103 -8,347	-22%	-$20.8K	0.1%	103
2025 Q1	$83.5K	Sell	37,450 -385	-1%	-$1.1K	0.09%	105
2024 Q4	$111K	Sell	37,835 -10,680	-22%	-$29.7K	0.09%	141
2024 Q3	$126K	Buy	48,515 +23,806	+96%	+$66K	0.1%	132
2024 Q2	$73.1K	Sell	24,709 -3,638	-13%	-$13.8K	0.06%	135
2024 Q1	$128K	Buy	28,347 +520	+2%	+$2.65K	0.09%	140
2023 Q4	$159K	Sell	27,827 -11,537	-29%	-$53.5K	0.11%	148
2023 Q3	$181K	Sell	39,364 -15,051	-28%	-$91.6K	0.14%	145
2023 Q2	$352K	Buy	54,415 +6,672	+14%	+$45.5K	0.23%	122
2023 Q1	$360K	Sell	47,743 -950	-2%	-$8.63K	0.25%	120
2022 Q4	$493K	Sell	48,693 -451	-0.9%	-$5.21K	0.41%	97
2022 Q3	$486K	Sell	49,144 -447	-0.9%	-$4.9K	0.41%	109
2022 Q2	$528K	Buy	49,591 +15,578	+46%	+$132K	0.12%	125
2022 Q1	$332K	Buy	34,013 +5,846	+21%	+$55.4K	0.22%	123
2021 Q4	$403K	Buy	28,167 +3,979	+16%	+$60.4K	0.27%	115
2021 Q3	$485K	Buy	+24,188	New	+$428K	0.33%	115